DUSP12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.651234704525E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.22044604925031E-16 |
Normal-vs-Stage2 |
4.10550000000676E-05 |
Normal-vs-Stage3 |
2.10979999999417E-05 |
Normal-vs-Stage4 |
2.45509999999838E-05 |
Stage1-vs-Stage2 |
2.306000E-01 |
Stage1-vs-Stage3 |
2.555400E-03 |
Stage1-vs-Stage4 |
2.001700E-03 |
Stage2-vs-Stage3 |
3.352400E-01 |
Stage2-vs-Stage4 |
2.893600E-01 |
Stage3-vs-Stage4 |
9.469200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.5442763975152E-13 |
Normal-vs-AfricanAmerican |
1.17449999947894E-07 |
Normal-vs-Asian |
4.442400E-04 |
Caucasian-vs-AfricanAmerican |
2.757800E-02 |
Caucasian-vs-Asian |
5.603400E-01 |
AfricanAmerican-vs-Asian |
6.811600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.28610455618627E-11 |
Normal-vs-Female |
1.67721392330122E-12 |
Male-vs-Female |
5.856000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.036700E-03 |
Normal-vs-Age(41-60Yrs) |
3.69330122040878E-11 |
Normal-vs-Age(61-80Yrs) |
3.98792110445356E-13 |
Normal-vs-Age(81-100Yrs) |
2.483700E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.950600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.831200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.753200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.475200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.403600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.628600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.5745963400966E-11 |
Normal-vs-Grade 2 |
<1E-12 |
Normal-vs-Grade 3 |
8.08900002535751E-09 |
Normal-vs-Grade 4 |
3.575800E-03 |
Grade 1-vs-Grade 2 |
7.839800E-02 |
Grade 1-vs-Grade 3 |
5.978100E-03 |
Grade 1-vs-Grade 4 |
1.392980E-04 |
Grade 2-vs-Grade 3 |
2.298000E-03 |
Grade 2-vs-Grade 4 |
5.75959999999931E-05 |
Grade 3-vs-Grade 4 |
8.879900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62436730732907E-12 |
Normal-vs-ccB subtype |
7.81690000000168E-05 |
ccA subtype-vs-ccB subtype |
2.65460000004047E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.06670014435417E-10 |
Normal-vs-N1 |
5.980400E-02 |
N0-vs-N1 |
9.455000E-01 |
|
|